Back to Search
Start Over
[Resurgence of Mycoplasma pneumoniae: a new epidemic ?]
- Source :
-
Revue medicale suisse [Rev Med Suisse] 2024 Nov 13; Vol. 20 (895), pp. 2093-2098. - Publication Year :
- 2024
-
Abstract
- Mycoplasma pneumoniae pneumonia occurs periodically in an endemic-epidemic pattern. The incidence of this disease has fallen drastically as a result of the health measures imposed for the COVID-19 pandemic. In Switzerland, as elsewhere in the world, a new epidemic has been affecting pediatrics and adult populations since September 2023. Transmitted by aerosols and requiring close contact, this bacterium causes respiratory infections of varying severity, as well as a variety of extra-pulmonary manifestations. Microbiological diagnosis is based on PCR of respiratory samples. Despite a very high rate of macrolide resistance in Asia, the resistance rate remains low in Europe.<br />Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
- Subjects :
- Humans
Switzerland epidemiology
Epidemics
Adult
COVID-19 epidemiology
COVID-19 diagnosis
Drug Resistance, Bacterial
Anti-Bacterial Agents therapeutic use
Macrolides therapeutic use
Incidence
Child
Pneumonia, Mycoplasma epidemiology
Pneumonia, Mycoplasma diagnosis
Mycoplasma pneumoniae isolation & purification
Subjects
Details
- Language :
- French
- ISSN :
- 1660-9379
- Volume :
- 20
- Issue :
- 895
- Database :
- MEDLINE
- Journal :
- Revue medicale suisse
- Publication Type :
- Academic Journal
- Accession number :
- 39544054
- Full Text :
- https://doi.org/10.53738/REVMED.2024.20.895.2093